Health-related quality of life as a predictor of tuberculosis treatment outcomes in Iraq

International Journal of Infectious Diseases

Volumn 31, Issue 1, 2015, Pages 4-8

  Dujaili, Juman Abdulelah ^a   Sulaiman, Syed Azhar Syed ^a   Hassali, Mohamed Azmi ^a   Awaisu, Ahmed ^b   Blebil, Ali Qais ^c   Bredle, Jason M ^d  

^a SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

^b Qatar University ^*  (Qatar)

^c UCSI UNIVERSITY   (Malaysia)

^d FACITorg Translations   (United States)

Author keywords

FACIT; FACT G; HRQL; Outcome; Treatment; Tuberculosis

Indexed keywords

TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; IRAQ; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; QUALITY OF LIFE; TREATMENT OUTCOME; TUBERCULOSIS; WELLBEING; CHRONIC DISEASE; MIDDLE AGED; PSYCHOLOGY; QUESTIONNAIRE; TUBERCULOSIS, PULMONARY;

ADULT; CHRONIC DISEASE; COHORT STUDIES; FEMALE; HUMANS; IRAQ; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; SURVEYS AND QUESTIONNAIRES; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY;

EID: 84930942619     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2014.12.004     Document Type: Article

References (31)

1. Morgan M. Health status and health policy: allocating resources to health care. Am J Epidemiol 1994;139:1226-8.
2. Bauer M, Leavens A, Schwartzman K. A systematic review and meta-analysis of the impact of tuberculosis on health-related quality of life. Qual Life Res 2012;22:1-23.
3. Guo N, Marra F, Marra CA. Measuring health-related quality of life in tuberculosis: a systematic review. Health Qual Life Outcomes 2009;7:14.
4. Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi AE, et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 1993;11:570-9.
5. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365-76.
6. Aaronson NK, Bullinger M, Ahmedzai S. A modular approach to quality-of-life assessment in cancer clinical trials. In: Scheurlen H, Kay R, Baum M, editors. Cancer clinical trials. Berlin: Springer; 1988. p. 231-49.
7. Webster K, Cella D, Yost K. The Functional Assessment of Chronic Illness Therapy (FACIT) measurement system: properties, applications, and interpretation. Health Qual Life Outcomes 2003;1:79.
8. Chamla D. The assessment of patients' health-related quality of life during tuberculosis treatment in Wuhan, China. Int J Tuberc Lung Dis 2004;8:1100-6.
9. Deribew A, Tesfaye M, Hailmichael Y, Negussu N, Daba S, Wogi A, et al. Tuberculosis and HIV co-infection: its impact on quality of life. Health Qual Life Outcomes 2009;7:105-11.
10. Dhuria M, Sharma N, Singh Narender Pal, Jiloha Ram Chander, Saha R, Ingle Gopal Krishan. A study of the impact of tuberculosis on the quality of life and the effect after treatment with DOTS. Asia Pac J Public Health 2009;21:312-20.
11. Dion MJ, Tousignant P, Bourbeau J, Menzies D, Schwartzman K. Feasibility and reliability of health-related quality of life measurements among tuberculosis patients. Qual Life Res 2004;13:653-65.
12. Guo N, Marra CA, Marra F, Moadebi S, Elwood RK, FitzGerald JM. Health state utilities in latent and active tuberculosis. Value Health 2008;11:1154-61.
13. Marra CA, Marra F, Colley L, Moadebi S, Elwood RK, Fitzgerald JM. Healthrelated quality of life trajectories among adults with tuberculosis: differences between latent and active infection. Chest 2008;133:396-403.
14. Dujaili JA, Blebil AQ, Awaisu A, Bredle J, Dujaili MA, Hassali MA, et al. Development of a multi-dimensional health related quality of life measure specific for pulmonary tuberculosis patients in Iraq. Value Health 2013;16:A95-6.
15. Chang B, Wu AW, Hansel NN, Diette GB. Quality of life in tuberculosis: a review of the English language literature. Qual Life Res 2004;13:1633-42.
16. Moran MG. Psychiatric aspects of tuberculosis. Adv Psychosom Med 1985;14:109-18.
17. Pachi A, Bratis D, Moussas G, Tselebis A. Psychiatric morbidity and other factors affecting treatment adherence in pulmonary tuberculosis patients. Tuberc Res Treat 2013;2013:37.
18. Chan-Yeung M, Noertjojo K, Leung CC, Chan SL, Tam CM. Prevalence and predictors of default from tuberculosis treatment in Hong Kong. Hong Kong Med J 2003;9:263-8.
19. Kitahata MM, Tegger MK, Wagner EH, Holmes KK. Comprehensive health care for people infected with HIV in developing countries. BMJ 2002;325:954-7.
20. Duyan V, Kurt B, Aktas Z, Duyan GC, Kulkul DO. Relationship between quality of life and characteristics of patients hospitalised with tuberculosis. Int J Tuberc Lung Dis 2005;9:1361-6.
21. Louw J, Peltzer K, Naidoo P, Matseke G, Mchunu G, Tutshana B. Quality of life among tuberculosis (TB), TB retreatment and/or TB-HIV co-infected primary public health care patients in three districts in South Africa. Health Qual Life Outcomes 2012;10:77.
22. Unalan D, Soyuer F, Ceyhan O, Basturk M, Ozturk A. Is the quality of life different in patients with active and inactive tuberculosis? Indian J Tuberc 2008;55:127-37.
23. Steffen R, Menzies D, Oxlade O, Pinto M, de Castro AZ, Monteiro P, et al. Patients' costs and cost-effectiveness of tuberculosis treatment in DOTS and non-DOTS facilities in Rio de Janeiro, Brazil. PLoS One 2010;5:e14014.
24. Vogl M, Wenig C, Leidl R, Pokhrel S. Smoking and health-related quality of life in English general population: implications for economic evaluations. BMC Public Health 2012;12:203.
25. Toghianifar N, Najafian J, Pooya A, Rabiei K, Eshrati B, Anaraki J, et al. Association of smoking status with quality of life in a cross-sectional population-based sample of Iranian adults: Isfahan healthy heart program. Asia Pac J Public Health 2012;24:786-94.
26. Heikkinen H, Jallinoja P, Saarni SI, Patja K. The impact of smoking on healthrelated and overall quality of life: a general population survey in Finland. Nicotine Tob Res 2008;10:1199-207.
27. Dujaili JA, Syed Sulaiman SA, Awaisu A, Muttalif AR, Blebil AQ. Outcomes of tuberculosis treatment: a retrospective cohort analysis of smoking versus nonsmoking patients in Penang, Malaysia. J Public Health 2011;19:183-9.
28. Awaisu A, Haniki Nik Mohamed M, Noordin N, Muttalif A, Aziz N, Syed Sulaiman S, et al. Impact of connecting tuberculosis directly observed therapy shortcourse with smoking cessation on health-related quality of life. Tob Induc Dis 2012;10:2.
29. Awaisu A, Nik Mohamed M, Mohamad Noordin N, Abd Aziz N, Syed Sulaiman S, Muttalif A, et al. The SCIDOTS Project: evidence of benefits of an integrated tobacco cessation intervention in tuberculosis care on treatment outcomes. Subst Abuse Treat Prev Policy 2011;6:1-13.
30. Dhingra VK, Rajpal S. Health related quality of life (HRQL) scoring (DR-12 score) in tuberculosis-additional evaluative tool under DOTS. J Commun Dis 2005;37:261-8.
31. Guyatt GH, King DR, Feeny DH, Stubbing D, Goldstein RS. Generic and specific measurement of health-related quality of life in a clinical trial of respiratory rehabilitation. J Clin Epidemiol 1999;52:187-92.